should i switch from tirzepatide to retatrutide vs. Retatrutide: Key Differences Explained Why I Switched From Tirzepatide
Description
New Dual Incretin Agonist for Type 2 Diabetes This first-in-class, once-weekly injectable agent has demonstrated significant positive outcomes in reducing A1C and weight in clinical trials
Reduced Food Obsession Many people report a significant decrease in food cravings and constant thoughts about eating
Providers that obscure the compounded nature of their medications deserve more skepticism, not less
.webp)
The shorter date is more conservative, not less legitimate
Follow this decision tree in order
Author Contributions Hamza A
